Literature DB >> 7919350

Structural requirements of platelet chemokines for neutrophil activation.

Z Yan1, J Zhang, J C Holt, G J Stewart, S Niewiarowski, M Poncz.   

Abstract

Using recombinantly expressed proteins and synthetic peptides, we examined the structural/functional features of the platelet chemokines, neutrophil-activating peptide-2 (NAP-2) and platelet factor 4 (PF4); that were important in their activation of neutrophils. Previous studies with the chemokine interleukin-8 (IL-8) had shown that the N-terminal region preceding the first cysteine residue was critical in defining neutrophil-activating properties. We examined whether NAP-2 and PF4 had similar structural requirements. In the Ale-glu-leu-arg (AELR) N-terminus of NAP-2, substitution of E or R abolished Ca2+ mobilization and elastase secretion. Unlike the parent molecule PF4, AELR/PF4, the hybrid formed by replacing the N-terminal sequence of PF4 before the first cysteine residue with the homologous sequence of NAP-2, stimulated Ca2+ mobilization and elastase secretion. Furthermore, the effect of amino acid substitutions in the ELR motif differed from those seen with NAP-2 in that conserved substitutions of E or R in NAP-2 abolished activity, but only reduced neutrophil activation in the hybrid. These studies show that just as with IL-8, the N-termini of NAP-2 and PF4 are critical for high-level neutrophil-activating function. Desensitization studies provided information on receptor binding. NAP-2, which binds almost exclusively to the type 2 IL-8 receptor (IL-8R), did not desensitize neutrophils to activation by IL-8 because IL-8 could bind to and activate via both type 1 and 2 IL-8R. AELR/PF4 appears to bind to both types of receptors because it desensitized neutrophils to NAP-2 activation; but was not desensitized by NAP-2, and because it desensitized to and was desensitized by IL-8. Thus, although NAP-2 and AELR/PF4 share approximately 60% amino acid homology, they have different receptor affinities. Studies were performed to define the role of the C-termini of these platelet chemokines in receptor binding. Heparin and a monoclonal antibody specific for the heparin-binding domain of PF4 both inhibited Ca2+ mobilization and elastase release, further suggesting that the C-terminus of these chemokines is important in receptor binding. Synthetic NAP-2(51-70) failed to mobilize Ca2+, whereas PF4(47-70) and PF4(58-70) induced Ca2+ mobilization and secretion of elastase at high concentrations. Pertussis toxin inhibited neutrophil activation by 40% to 50%, establishing a role for G-protein-coupled receptors such as the IL-8Rs in activation by the PF4 C-terminal peptides.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919350

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

Review 2.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

Review 3.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

4.  Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage.

Authors:  Rundk Hwaiz; Milladur Rahman; Enming Zhang; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2015-10-24       Impact factor: 8.739

5.  Rac1 regulates platelet shedding of CD40L in abdominal sepsis.

Authors:  Rundk Hwaiz; Milladur Rahman; Enming Zhang; Henrik Thorlacius
Journal:  Lab Invest       Date:  2014-07-21       Impact factor: 5.662

6.  Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury.

Authors:  Khalil Bdeir; Kandace Gollomp; Marta Stasiak; Junjie Mei; Izabela Papiewska-Pajak; Guohua Zhao; G Scott Worthen; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

7.  A synthetic congener modeled on a microbicidal domain of thrombin- induced platelet microbicidal protein 1 recapitulates staphylocidal mechanisms of the native molecule.

Authors:  Yan Q Xiong; Arnold S Bayer; Lisa Elazegui; Michael R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

8.  Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis.

Authors:  Analia E Garcia; Sripal R Mada; Mario C Rico; Raul A Dela Cadena; Satya P Kunapuli
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

9.  Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.

Authors:  Jiacheng Huang; Zhitao Chen; Chenchen Ding; Shengzhang Lin; Dalong Wan; Kuiwu Ren
Journal:  Front Oncol       Date:  2021-08-23       Impact factor: 6.244

10.  Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.

Authors:  Toshiro Kinouchi; Motohide Uemura; Cong Wang; Yu Ishizuya; Yoshiyuki Yamamoto; Takuji Hayashi; Kyosuke Matsuzaki; Wataru Nakata; Takahiro Yoshida; Kentaro Jingushi; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Kazutoshi Fujita; Ryoichi Imamura; Yuko Ueda; Kaori Kitae; Kazutake Tsujikawa; Norio Nonomura
Journal:  Cancer Sci       Date:  2017-10-25       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.